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ABSTRACT 
 
Mucoadhesive polymers that bind to the gastric mucin 
or epithelial cell surface are useful in drug delivery for 
the purpose of increasing the intimacy and duration of 
contact of drug with the absorbing membrane. Several 
synthetic polymers are in use for this purpose.  Since 
the biodegradability of the synthetic polymers are 
questionable, in this investigation an oral 
mucoadhesive controlled delivery system has been 
developed for terbutaline sulphate (TS) using natural 
mucoadhesive materials extracted from the edible 
fruits like Zizyphus mauritiana (ZM) and Aegle 
marmelos (Linn.) Cor. (AM) that have better 
mucoadhesive property than synthetic polymer 
hydroxypropylmethylcellulose K4M (HPMC K4M). 
The in vitro  adhesive and mucoadhesive strength of 
mucoadhesive materials extracted from the  fruits of 
ZM and AM were evaluated and compared with 
HPMCK4M using both Share Stress and Wilhelmy 
Plate. Different formulations of oral mucoadhesive 
coated TS tablets were prepared using these natural 
materials and compared with tablets prepared with 
HPMCK4M and hardness, thickness, friability, weight 
variation and drug content of tablets were tested. The 
in vitro release of TS was studied in buffer pH 7.2 at 
370C  0.50C. Tablets were orally administered to 
rabbits and blood plasma concentration of TS was 
determined using HPLC. It was found that 
mucoadhesive materials extracted from the fruits of 
ZM and AM exhibited better adhesiveness and 
mucoadhesiveness as compared with the HPMC- 
K4M. The in vitro study of TS exhibited showed 
greater drug release profile for tablets prepared with 
natural materials than synthetic polymers and 
confirmed with in vivo study. In vitro and in vivo 
correlation showed the same release profile. 
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INTRODUCTION 
 
Mucoadhesion, or the attachment of a 
natural or synthetic polymer to a biological substrate, 
is a practical method of drug immobilization or 
localization and an important new aspect of controlled 
drug delivery (1). While the subject of mucoadhesion 
is not new, there has been increased interest in recent 
years in using mucoadhesive polymers for drug 
delivery (2-3). Substantial effort has recently been 
focused on placing a drug or a formulation in a 
particular region of the body for extended periods of 
time (4). This is needed not only for targeting of drugs 
but also to better control of systemic drug delivery. 
Drugs that are absorbed through the mucosal lining of 
tissues can enter directly into the blood stream and not 
be inactivated by enzymatic degradation in the 
gastrointestinal tract (5). Several polymeric 
bioadhesive drug delivery systems have been 
fabricated and studied in the past. Different types of 
bioadhesive synthetic polymers such as acrylic-based 
hygrogels (6) including carbopol 934, carbopol 937 
andhydroxypropylmethylcellulose are used to prepare 
oral mucoadhesive tablets. (7) However, the 
adhesiveness and drug delivery capabilities of these 
devices can continue to be improved, as presently 
known bioadhesive materials, and more bioadhesive 
materials are discovered (8-19). 
 
Since the biodegradability of the synthetic 
polymers is questionable, some natural mucoadhesive 
materials extracted from edible fruits and vegetables 
having good mucoadhesive properties are used for this 
purpose (20).Terbutaline Sulphate (TS) is widely used 
as an effective bronco-dilator in the management of 
asthma (21). This is used as prophylactic drug as well 
as to prevent acute exacerbations of asthma. During 
acute attack of asthma it becomes difficult for a 
patient to take oral medications repeatedly. Hence, it is 
rational to administer terbutaline sulphate(TS) in a 
sustained release dosage form, which will minimize 
repeated administration of drug.  
 
The objective of the present study was (a) to 
prepare mucoadhesive controlled release TS tablets 
using natural mucoadhesive materials including  ZM 
and AM, and synthetic polymer HPMCK4M, (b) to 
examine the in vitro release characteristics of TS from 
formulated tablets, (c) to examine the in vivo drug 
absorption characteristics of TS in rabbit blood plasma 
from formulated tablets and (c) to make a correlation 
between in vitro release characteristics of TS and in 
vivo absorption characteristics of TS in rabbit blood 
plasma. 
 
MATERIALS AND METHODS  
MATERIALS 
 
Terbutaline sulphate (TS), metaproterenol 
hemisulphate and HPMCK4M were obtained as  gift 
samples from M/S Union Drugs Ltd, Kolkata, India. 
Acetone GR was procured from M/S Loba Chemicals, 
Mumbai, India. Dihydrogen potassium phosphate LR 
was purchased from Process Chemical Ltd, Kolkata, 
Indis. Monobasic potassium phosphate LR, absolute 
ethanol and pancreatin were procured from E. Marck 
(India) Ltd, Mumbai. Terbutaline sulphate RS was 
collected from Central Drug Laboratory, Kolkata, 
India.  The fruits of Zizyphus mauritiana (ZM) and 
Aegle marmelos (Linn.) Cor. (AM) were purchased 
from local market of India. 
 
Extraction materials such as solid phase 
extraction columns were 3 ml polypropylene columns 
packed with 200 mg of C18 bonded phase from J.T. 
Baker (Phillipsburg, NJ, U.S.A.). Reagent grade 
JPRHC 
Research Article 
JPRHC      January 2010         Volume 2             Issue 1              32-45  
 
monobasic and dibasic sodium phosphates were from 
Mallinckrodt Specialty Chemicals Co. (Chesterfield, 
MO, U.S.A.). Molecular biology grade ammonium 
chloride and Sigma Ultra grade reduced glutathione 
were from Sigma Chemical Co. Syringe filters were 4 
mm diameter, 0.2 m porosity nylon membrane units 
from Alltech Associates (Deerfield, IL, U.S.A.). 
Mobile phase materials such as monobasic potassium 
phosphate and anhydrous dibasic sodium phosphate 
were reagent grade from Mallinckrodt. The remaining 
mobile phase reagents were of HPLC grade and 
obtained from commercial sources. The 47 diameter, 
0.2 m porosity polyvinylidene difluoride (PVDF) 
filtration membranes were from Gelman Sciences 
(Ann Arbor, MI, U.S.A.). 
 
 
METHODS 
 
Extraction of mucoadhesive agents from ZM and 
AM:
 
 
The mucilage from above materials was 
extracted a modified method of Rao et al (22). In this 
method, 250 gm edible fruits of ZM  and AM were 
soaked in 1000 ml of double distilled water and boiled 
for 5 hrs in a water bath until a slurry was formed. The 
slurry was cooled and kept in refrigerator overnight so 
that most of the undissolved portion was settled down. 
The clear solution was decanted off and centrifuged at 
500 rpm 20 min. The supernatant was concentrated at 
600C on a water bath until the volume reduced to one 
third of its original volume. Solution was cooled down 
to the room temperature and was poured into thrice the 
volume of acetone by continuous stirring. The 
precipitate was washed repeatedly with acetone and 
dried at 500C under vacuum. The dried material was 
powdered and kept in a desiccator.  
 
Shear Stress Method: 
 
Two smooth, polished plexi glass blocks 
were selected; one block was fixed with adhesive 
‘Araldide’ on a glass plate, which fixed on leveled 
table. To the upper block a thread was tied and the 
thread was passed down through a pulley. At the end 
of the thread a beaker was fixed. The length of the 
thread from pulley to beaker was 7 cms. The weight of 
the beaker was counteracted. The volume of 0.75% 
w/v solution of natural mucoadhesive materials 
extracted from the fruits of ZM, AM and HPMCK4M 
were prepared using purified water I.P. as solvent. A 
fixed volume (0.5 ml) of 0.75% w/v solution of 
HPMCK4M and natural bioadhesive material 
solutions of ZM and AM were kept on the centre of 
the fixed block with a pipette, and then second block 
was placed on the first block and pressed by applying 
100 gm of weight, so that the drop of synthetic 
polymer and natural bioadhesive material solutions 
spreads as a uniform film in between the two blocks. 
After keeping it for a fixed time intervals of 5,10,15, 
and 20 min, purified water was added into the beaker 
gradually, the weight of purified water just sufficient 
to pull the upper block or to make it slide down from 
the base block was recorded. This weight was 
considered as the adhesion strength, i.e. shear stress 
required to measure the adhesion. Before every 
experimentation care was taken so that no air bubble 
form in between the two blocks, which may give 
erratic results, and the distance from pulley to glass 
block was always same in all observations (22). 
 
Wilhelmy Plate Method: 
 
Mucoadhesiveness of natural materials and 
HPMCK4M were determined by a modified method 
of Wilhelmy Plate. In this method small glass plates 
were coated uniformly by HPMCK4M and natural 
bioadhesive material solutions and dried at 600 C. The 
prepared coated plates were immersed in U.S.P. 
simulated intestinal fluid (pH 6.0) for 5, 10, 15, and 20 
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min, at room temperature. The force required to pull 
the plate out of the solution was determined under 
constant experimental conditions (4). 
 
 
Preparation of mucoadhesive tablets: 
 
Mucoadhesive coated tablets each 
containing 7.5 mg of TS were prepared by 
conventional wet granulation method employing part 
of the mucoadhesive materials as filler and part of the 
natural mucoadhesive materials and HPMCK4M  as 
binding agent as per the formulae given in Table 1. A 
blend of all ingredients was granulated with water. 
The wet masses were passed through 12-mesh sieve 
and the resulting granules were dried at 600C for 24 h. 
The dried granules were passed through 18-mesh 
sieve. After blending with talc and magnesium stearate 
in a laboratory cube blender for 10 min, they were 
compressed into 100 mg tablets to a harness of 4-5 
kg/cm2 on a single punch tablet machine. All the 
prepared tablets were coated with 1% w/v aqueous 
solution of natural mucoadhesive materials and 
HPMCK4M and then evaluated for hardness, 
friability, average weight and disintegration time (23). 
 
Identification and Estimation of TS Tablets: 
 
The identification test and away of TS were 
performed as per the procedure of Indian 
Pharmacopoea. A quantity of the powdered tablets 
equivalent to 20 mg of TS was shaken with 50 ml of 
0.1M sodium hydroxide for 10 minutes, and diluted to 
100 ml with 0.1M sodium hydroxide and it was 
filtered. Then 20 ml of the filtrate was diluted to 50 ml 
with 0.1M sodium hydroxide. The light absorption in 
the range 200 to 400nm of the resulting solution 
exhibits  a maxima only at about  276 nm. To 
determine the percentage purity of TS, twenty tablets 
were powdered in a glass mortar. The powder 
equivalent to 5 mg of terbutaline sulphate was taken in 
a 50 ml volumetric flask. 30 ml of 0.01 (M) 
hydrochloric acid was added and stirred for 10 
minuets and then it was filtered. The first 5 ml of the 
filtrate was rejected. To 5 ml of the filtrate 35 ml 
buffer (phosphate buffer at pH 7.4) solution was 
added. Then 1.0 ml freshly prepared 2.0%w/v solution 
of 4-aminoantipyrine and 1.0 ml freshly prepared 
8.0% w/v solution of potassium ferricyanide were 
added to the solution with vigorous stirring. Then 
sufficient buffer solution was added to produce 50 ml. 
Exactly 75 seconds after the addition of the potassium 
ferricyanide solution, the absorbance of resultant 
solution was measured at 550 nm using distilled water 
as blank. The percentage of terbutaline sulphate was 
determined against 0.01% w/v solution of terbutaline 
sulphate R.S. as standard solution. Jasco double beam 
UV-VIS Spectophotometer (Model, V-530) was used 
for these purpose (24). 
 
In- vitro Drug release study: 
 
Release of TS from the mucoadhesive 
coated tablets was studied in phosphate buffer of pH 
7.2 (900 ml) as prescribed in the dissolution rate test 
of TS tablets in USP XXIV (Method A) using USP 
Apparatus ll by the rotation of the paddle at 100 rpm. 
Samples were withdrawn through a filter (0.45µm) at 
different time intervals, suitably diluted and assayed 
for TS at 276 nm. Drug release experiments were 
conducted in triplicate (25). 
 
In- vivo Drug absorption study: 
 
Apparatus 
The mobile phase was pumped through the 
system by a reciprocating piston pump (Model LC 10-
AD, Shimadzu Scientific Instruments, Colombia, MD, 
U.S.A.). Samples were injected using a variable 
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injection volume autoinjector (Model AS-300, Spectra 
Physics Analytical, Fremont, CA, U.S.A.).  
 
The prepacked 5 m C 18 guard column was 
from Alletch Associates.The analytica column was a 
150 x 4.6 mm Dynamax column from Rinin 
Instrument Co. (Woburn, MA, U.S.A.) packed with 5 
m, 100 angstrom pore size, Microsorb  silica C 18  
stationary phase. Analytes were detected using a 
Coulochem ll amperometric detector with a Model 
5011 high sensitivity flow cell and a Model 5020 
guard cell, all from ESA Inc. (Bedford, MA, U.S.A.). 
The detector signal was processed on a Shimadzu 
model CR 501 computing integrator. 
Chromatographic Conditions 
The mobile phase was 25 mM phosphate 
buffer, pH 7.4 : methanol (77:23, vol/vol), with 2 mM 
1-octanesulfonic acid. It was filtered, degassed by 
sonication and pumped through the system at a flow 
rate of 0.7 ml/min, at room temperature. The 
electrochemical detector guard cell was set at +700 
mV potential. The analytical cell screen electrode was 
set at + 450 mV and the analytical electrode were set 
at + 700 mV potential. The signal filter was set to 0.2 
seconds. These potential were based on 
recommendations from an application note from the 
detector manufacturer and experiments our laboratory 
showing terbutaline begins to oxidize at a potential of 
about +450 mV. This low potential was used for the 
analytical cell screen electrode to improve sensitivity, 
realizing this would also cause a loss of selectivity. 
Detector response peaked at about +1000 mV, but 
running at this potential caused rapid loss of response, 
due to fouling of the electrode by oxidizable materials 
from the sample. The + 700 mV was selected as the 
potential for the analytical electrode to minimize 
fouling of the electrode and also to minimize the size 
(and thus interference) of the glutathione peak. 
Running at +700 mV required periodic storing of the 
column and rinsing the system with a mobile phase 
containing 0.9 M acetic acid to remove materials 
absorbed to the electrodes. 
Extraction Procedure 
Six health male albino rabbits weighing 
between 2.5-3.0 kg were fasted overnight. The oral TS 
tablets (7.5 mg) were administered to rabbits. At 
determination time intervals, 1 ml blood samples were 
withdrawn from the marginal ear vein. One milliliters 
of plasma were added to a culture tube. 20 l of a 1 
ng/ l solution of metaproterenol (internal standard) in 
methanol and 1 ml of 10 mM sodium phosphate buffer 
(pH 7.5) were then added, and the samples mixed. 
Solid phase extraction columns were preconditioned 
with 2 X 3 ml of ethanol, followed by 2 X 3 ml water. 
Plasma samples were then passed through columns. 
They were next to rinsed with 2 X 3 ml of water. 
Receiver tubes containing 50 l of 50 mM glutathione 
were then placed inside the vacuum manifold. The 
drugs were eluted from the columns with 1 ml of 95:5 
(vol/vol) ethanol: 50 mM ammonium chloride buffer, 
pH 8.5. The samples were dried under nitrogen in a 
water bath at 30 0C, reconstituted with 200 l of 
mobile phase, vorted-mixed, and transferred to 1.5 ml 
microcentrifuge tubes. The tubes were centrifuged at 
13,400 x g for 2 minutes. Each sample was then 
passed through a syringe filter into a conical 
polypropylene autosampler vial. The auto sampler was 
programmed to inject 170 l of each sample.  
The Institutional Ethics Committee has approved and 
given the permission to conduct the in vivo study 
using healthy rabbits (26). 
 
RESULTS AND DISCUSSIONS 
 
Natural mucoadhesive material obtained 
from the fruits of AM (27-30) and ZM (31-32) are 
reported to be nontoxic. The results obtained from 
Shear Stress and Wilhelmy Plate method are presented 
in Figure 1 and 2. From these figures it is confirmed 
that the mucoadhesive materials extracted from the 
fruits of ZM and AM showed better adhesive and 
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mucoadhesive property than the synthetic polymer 
HPMCK4M. The adhesive and mucoadhesive strength 
of this synthetic polymer and natural mucoadhesive 
materials was increased with time and it was 
maximum in case of material extracted from the fruits 
of ZM and minimum in case of HPMCK4M.
. 
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Figure 1: Results of adhesiveness extracted from ZM, AM and HPMCK4M* by Shear  
               Stress Method. 
*Weight required was average of six determination ( SD).  0.75% w/v solution of synthetic polymer and mucoadhesive 
materials in  purified water I.P. was used. 
 
     
Figure 2: Results of mucoadhesiveness extracted from ZM, AM and HPMCK4M* by  
                 Wilhelmy Plate Method. 
 
    *Weight required was average of six determination ( SD).  0.75% w/v solution of synthetic polymer and 
mucoadhesive materials in  purified water I.P. was used. 
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Table 1. Formulations of Coated Tablets of TS. 
 
 
No. Ingredient Formulation 
 (mg/tablet) F1 F2 F3 F4 F5 F6 
1. TS 7.5 7.5 7.5 7.5 7.5 7.5 
2. 
Extract of ZM 
7.5 - - 15 - - 
3. 
Extract of AM 
- 
 
7.5 - - 15 - 
4. H.P.M.C. K4M - - 7.5 - - 15 
5. Dibasic calcium phosphate 83 83 83 75.5 75.5 75.5 
6. Magnesium stearate 1 1 1 1 1 1 
7. Talc 1 1 1 1 1 1 
 
 
 
 
Figure 3: Release Profiles of Mucoadhesive Tablets of TS*. 
 
*Average of the six dimensions ( SD). Only batches F1 and F2 release drug up to 12h.  
  In case of other batches total amount of drug was released before 12h. 
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Figure 4: Mean plasma concentration of TS (mcg/ml) of different batches*. 
                *Average of the six dimensions ( SD) were used. 
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Figure 5: Relationship between percent TS released in-vitro and absorbed  
                in-vivo for batch F1*. 
              *Average of the six dimensions ( SD) were use 
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Figure 6: Relationship between percent TS released in-vitro and absorbed  
                in-vivo for batch F2*. 
              *Average of the six dimensions ( SD) were used.  
 
The desired sustained release rate of TS for 
all the batches followed zero order kinetic after a lag 
time of 1.0 h and up to 95.5% was released and gave 
slow release over a period of 12h. for the tablets of TS 
prepared by natural mucoadhesive materials obtained 
from the  fruits of ZM and AM in 1:1 drug-polymer 
ratio (batch F1 and F2) (Figure 3). This extension of 
release time is greater than the tablets prepared by 
HPMCK4M in the same drug-polymer ratio (batch 
F3). Tablets prepared by the natural mucoadhesive 
materials in 1:2 drug : mucoadhesive materials ratio 
(batch F4 and F5) showed extended release  over a 
period of 11 h. Total about 95% drug was released at 
that period and this extension of release time is also 
greater than the tablets prepared by HPMCK4M (10h) 
in the same drug-polymer ratio (batch F6). Plasma TS 
concentrations and standard deviations achieved 
following oral administration of the different batches 
are shown graphically in Figure 4. Formulated 
mucoadhesive tablets prepared by natural materials 
were compared to a formulation prepared by 
HPMCK4 in order to determine their relative 
availability and mucoadhesive characteristics. From 
these results it was confirmed that batches F1 and F2 
which were prepared by natural materials and where 
drug-mucoadhesive material ratio is 1:1 exhibited a 
smooth and extended absorption phase upto 12 hours. 
But other batches which were prepared either by 
synthetic polymer HPMCK4M (batch F3 and F6) or 
natural materials but the amount of natural material 
was more than batches F1 and F2, did not show the 
same extended drug release property as compare to 
batches F1 and F2. It is also confirmed that if TS 
mucoadhesive tablets were prepared by natural 
materials extracted from ZM and AM in 1:1 drug: 
mucoadhesive material ratio shows the desired 
mucoadhesive property by in-vivo experiment. A 
direct correlation between the percent drug released 
and percent drug absorbed of batch F1 and F2 are 
plotted in Figure 5 and 6 (33). From these figures it is 
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confirmed that a good correlation exists between in-
vitro drug release and in-vivo drug absorption of two 
batches. These two batches have a much slower but 
continuous absorption as compared to other batches.  
 
CONCLUSION 
In conclusion, the results of the present 
study indicated that the formulation F1 which was 
prepared from the mucoadhesive materials extracted 
from the edible fruits of ZM and used in 1:1 drug: 
material ratio and the formulation F2 which was 
prepared from the  mucoadhesive materials extracted 
from the edible  fruits of AM and used in 1:1 drug: 
material ratio have shown promising results (release 
about 95.5% drug in 12 h) with reasonably good 
mucoadhesive properties of natural materials. 
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